13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 26 holding rows worth $11,136,250,185.
- Accession
- 0001104659-26-096427
- Filer
- CIK 1633313
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 26 entries on the cover page, a total value of $11,136,250,185 stated on the cover page (in dollars after the unit check, H1), rows summing to $11,136,250,185 with VALUE read as dollars as filed, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,777,777 | $1,505,082,912 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 5,111,111 | $1,363,235,526 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 2,888,888 | $1,073,713,003 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,833,333 | $984,408,154 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,000,000 | $927,770,000 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 11,355,555 | $925,591,288 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 7,474,747 | $857,129,238 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,297,000 | $430,182,160 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 4,999,999 | $425,949,915 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 3,400,000 | $355,708,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 6,555,555 | $351,836,637 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 5,777,777 | $348,746,620 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 7,188,888 | $338,165,292 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 6,727,777 | $309,881,409 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 5,723,888 | $245,612,034 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 23,888,888 | $162,683,327 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 12,540,000 | $123,142,800 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 3,783,000 | $98,395,830 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 1,925,150 | $70,710,760 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 1,800,000 | $48,384,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,500,000 | $45,925,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 1,337,500 | $44,792,875 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 2,333,333 | $43,119,994 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 1,444,039 | $36,100,975 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 2,849,402 | $13,050,261 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 1,489,189 | $6,932,175 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-096427 | this filing | 2026-08-14 | acceptance time not in the bulk data set |